Study details
Enrolling now
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
University of Miami
NCT IDNCT05607719ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 3 years
Ages
40–80
Locations
1 site in FL
What this study is about
Researchers are testing whether adding a short course of inhaled corticosteroids to your usual treatment for COPD improves how well your blood vessels respond to medication. The trial will last 1084 days and involve approximately 30 adults with stable COPD who are not currently taking an ICS.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Bevespi
- 2.Take Bretzri
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Percent change in FEV1
Body systems
Respiratory